Journal of Forensic and Legal Medicine
Volume 15, Issue 1 , Pages 48-52 , January 2008

Pneumoproteins as markers of paraquat lung injury: A clinical case

Received 21 August 2006 ,Accepted 27 September 2006.

References 

  1. Bismuth C, Hall AH, Wong A. Paraquat ingestion exposure: symptomatology and risk. In:  Bismuth C,  Hall AH editor. Paraquat poisoning: mechanisms-prevention-treatment. New York (NY): Marcel Dekker; 1995;p. 195–210
  2. Sato S. Human paraquat toxicology: prognostic factors. In:  Bismuth C,  Hall AH editor. Paraquat poisoning: mechanisms-prevention-treatment. New York, NY: Marcel Dekker; 1995;p. 267–274
  3. Suzuki K, Takasu N, Arita S, Maenosono A, Ishimatsu S, Nishina M, et al. A new method for predicting the outcome and survival period in paraquat poisoning. Hum Toxicol. 1989;8:33–38
  4. Hermans C, Bernard A. Lung epithelium specific proteins: characteristics and potential applications as markers. State of the art. Am J Respir Crit Care Med. 1999;159:646–678
  5. Hermans C, Bernard A. Pneumoproteinemia: a new perspective in the assessment of lung disorders. Eur Respir J. 1998;11:801–803
  6. Doyle IR, Hermans C, Bernard A, Nicholas TE, Bersten AD. Clearance of Clara cell secretory protein (CC16) and surfactant proteins A and B from blood in acute respiratory failure. Am J Respir Crit Care Med. 1998;158:1528–1535
  7. Rose MS, Smith LL, Wyatt I. Evidence for energy-dependent accumulation of paraquat into rat lung. Nature. 1974;252:314–315
  8. Bernard A, Dumont X, Roels H, Lauwerys R, Dierynck I, De Ley M, et al. The molecular mass and concentrations of protein 1 or Clara cell protein in biological fluids: a reappraisal. Clin Chim Acta. 1993;223:189–191
  9. Itoh Y, Ishii S, Okutani R, Asano Y, Kawai T. Protein 1: its purification and application in clinical medicine. J Clin Lab Anal. 1993;7:394–400
  10. Shijubo N, Itoh Y, Yamaguchi T, Shibuya Y, Morita Y, Hirasawa M, et al. Serum and BAL Clara cell 10kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers. Eur Respir J. 1997;10:1108–1114
  11. Bernard A, Marchandise FX, Depelchin S, Lauwerys R, Sibille Y. Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J. 1992;5:1231–1238
  12. Lesur O, Bernard A, Arsalane K, Lauwerys R, Begin R, Cantin A, et al. Clara cell protein (CC16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med. 1995;152:290–297
  13. Jorens PG, Sibille Y, Goulding NJ, van Overveld FJ, Herman AG, Bossaert L, et al. Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur Respir J. 1995;8:1647–1653
  14. Hermans C, Knoops B, Wiedig M, Arsalane K, Toubeau G, Falmagne P, et al. Clara cell protein (CC16) in experimental lung injury: assessment as marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J. 1999;13:1014–1021
  15. Hermans C, Osman A, Nyberg BI, Peterson C, Bernard A. Determinants of Clara cell protein (CC16) concentration in serum: a reassessment with two different immunoassays. Clin Chim Acta. 1998;272:101–110
  16. Bernard A, Thielemans N, Lauwerys R, Vandeleene B, Lambert AE. The renal handling of protein 1 (Clara cell protein): effect of age, sex, and renal dysfunction. Contrib Nephrol. 1993;101:66–70
  17. Kabanda A, Goffin E, Bernard A, Lauwerys R, van Ypersele de Strihou C. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int. 1995;48:1946–1952
  18. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest. 1991;88:1976–1981
  19. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med. 1996;153:176–184
  20. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med. 1999;160:1843–1850
  21. Veldhuizen RA, McCaig LA, Akino T, Lewis JF. Pulmonary surfactant subfractions in patients with the acute respiratory syndrome. Am J Respir Crit Care Med. 1995;152:1867–1871
  22. Phielps DS, Umstead TM, Mejia M, Carrillo G, Pardo A, Selman M. Increased surfactant protein-A levels in patients with newly diagnosed idiopathic pulmonary fibrosis. Chest. 2004;125:617–625
  23. Doyle IR, Bersten AD, Nicholas TE. Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure. Am J Respir Crit Care Med. 1997;156:1217–1229
  24. Horiuchi T, Mason JR, Kuroki Y, Cherniack RM. Surface and tissue forces, surfactant protein A, and the phospholipid components of pulmonary surfactant in bleomycin-induced pulmonary fibrosis in the rat. Am Rev Respir Dis. 1990;141:1006–1013
  25. Savani RC, Godinez RI, Godinez MH, Wentz E, Zaman A, Cui Z, et al. Respiratory distress after intratracheal bleomycin: selective deficiency of surfactant proteins B and C. Am J Physiol Lung Cell Mol Physiol. 2001;281:685–696
  26. Pan T, Nielsen LD, Allen MJ, Shannon KM, Shannon JM, Selman M, et al. Serum SP-D is a marker of lung injury in rats. Am J Physiol Lung Cell Mol Physiol. 2002;282:L824–L832
  27. Doyle IR, Nicholas TE, Bersten AD. Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med. 1995;152:307–317
  28. Hermans C, Dong P, Robin M, Jadoul M, Bernard A, Bersten AD, et al. Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16. Biomarkers. 2003;8:461–471

PII: S1353-1131(06)00212-4

doi: 10.1016/j.jcfm.2006.09.003

Journal of Forensic and Legal Medicine
Volume 15, Issue 1 , Pages 48-52 , January 2008

Article Tools

* Image Usage & Resolution